rhenium has been researched along with technetium tc 99m hydroxymethylene diphosphonate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franke, WG; Hliscs, R; Kropp, J; Liepe, K | 1 |
| Brenner, W; Brümmer, C; Czech, N; Henze, E; Kampen, WU; Muhle, C; von Forstner, C; Zuhayra, M | 1 |
2 other study(ies) available for rhenium and technetium tc 99m hydroxymethylene diphosphonate
| Article | Year |
|---|---|
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate | 2000 |
Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
Topics: Animals; Bone and Bones; Connective Tissue; Etidronic Acid; Female; Organometallic Compounds; Organophosphorus Compounds; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate; Urinary Bladder; Whole-Body Counting | 2003 |